Real-world treatments and thrombotic events in polycythemia vera patients in the USA

Polycythemia vera (PV) is a myeloproliferative neoplasm associated with increased risk of thrombotic events (TE) and death. Therapeutic interventions, phlebotomy and cytoreductive medications, are targeted to maintain hematocrit levels < 45% to prevent adverse outcomes. This retrospective observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstovsek, Srdan, Pemmaraju, Naveen, Reaven, Nancy L., Funk, Susan E., Woody, Tracy, Valone, Frank, Gupta, Suneel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977710/
https://www.ncbi.nlm.nih.gov/pubmed/36637474
http://dx.doi.org/10.1007/s00277-023-05089-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977710/
https://www.ncbi.nlm.nih.gov/pubmed/36637474
http://dx.doi.org/10.1007/s00277-023-05089-6

Ejemplares similares